Drug recall · July 13, 2016
Cyproheptadine Hydrochloride Syrup recall
Why: Subpotency: product assayed and found OOS for cyproheptadine
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48
- Lots / codes
Lot #: CR1603, Exp 12/17
- Quantity
- 12,215 Bottles shipped to Rising Pharmaceuticals
- Company
- Lyne Laboratories, Inc., Brockton, MA
- Distribution
- NJ
- Initiated
- June 7, 2016 · Voluntary: Firm initiated
- Classified
- July 5, 2016
- Reported
- July 13, 2016
- Ended
- February 3, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cyproheptadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.